{"id":14476,"date":"2019-11-11T08:26:31","date_gmt":"2019-11-11T13:26:31","guid":{"rendered":"https:\/\/medicarereport.org\/?p=14476"},"modified":"2019-11-11T08:26:31","modified_gmt":"2019-11-11T13:26:31","slug":"voters-say-congress-needs-to-curb-drug-prices-but-are-lawmakers-listening","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=14476","title":{"rendered":"Voters Say Congress Needs To Curb Drug Prices, But Are Lawmakers Listening?"},"content":{"rendered":"

(By Emmarie Huetteman for Kaiser Health News)<\/p>\n

House Democrats are poised to pass sweeping legislation to lower drug prices using strategies President Donald Trump has endorsed. A Trump aide urged the Republican-controlled Senate to vote on a different package curbing drug prices that was drafted by a senior Republican.<\/p>\n

But at least right now, neither measure appears likely to attract enough bipartisan support to become law.<\/p>\n

Nearly\u00a08 in 10 Americans\u00a0say the cost of prescription drugs is unreasonable, with voters from both parties agreeing that reducing the cost of prescription drugs should be one of Congress\u2019 top priorities, according to a poll last month by the Kaiser Family Foundation. (KHN is an editorially independent program of the foundation.)\u00a0 Continue reading article here…<\/a><\/p>\n

Kaiser Health News is a nonprofit national health policy news service that is part of the nonpartisan Henry J. Kaiser Family Foundation<\/p>\n

\"\"<\/a><\/p>\n

Notice:<\/strong> The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n","protected":false},"excerpt":{"rendered":"
(By Emmarie Huetteman for Kaiser Health News) House Democrats are poised to pass sweeping legislation to lower drug prices using<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10,15],"tags":[],"class_list":["post-14476","post","type-post","status-publish","format-standard","hentry","category-legislative-update","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/14476","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=14476"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/14476\/revisions"}],"predecessor-version":[{"id":14477,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/14476\/revisions\/14477"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=14476"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=14476"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=14476"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}